Jacqueline Garcia, MD

Medical Oncology

Jacqueline Garcia, MD

View full profile

Related Videos

Jacqueline Garcia, MD discussed results from the Phase # VERONA study Video

Jacqueline Garcia, MD discussed results from the Phase # VERONA study

Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven+Aza) versus placebo with azacititine (Pbo+Aza) in patients with treatment-naive, intermediate and higher-risk Myelodysplastic Syndromes (HR-MDS)

Jacqueline Garcia, MD on oral maintenance therapy in AML/MDS patients Video

Jacqueline Garcia, MD on oral maintenance therapy in AML/MDS patients

Jacqueline Garcia, MD, of Dana-Farber Cancer Institute presented at #ASH24 data suggesting oral maintenance therapy with venetoclax and decitabine/cedazuridine after HCT is safe, feasible, and may reduce relapse rates in high-risk AML/MDS patients.